Cite
HARVARD Citation
Frasca, F. et al. (2022). Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity. European journal of immunology. 52 (7), pp. 1120-1128. [Online].